Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by scarlet1967on Nov 18, 2021 5:54pm
154 Views
Post# 34143121

RE:RE:New post on LinkedIn

RE:RE:New post on LinkedIn I believe so this appearance although only in Quebec to me looks like they are nw ready to promote the platform based on their optimism re the results so far. It would be great if they would try similar promotional efforts in the US.
Wino115 wrote: Well, at the risk of embarassing yourself infront of whole Province, I guess this means we can assume they are seeing good things in the trial!

scarlet1967 wrote:

“Theratechnologies will be in the spotlight this Thursday, November 18 at 6:30 pm on the television channel TVA nouvelles in the program " vos affaires" of Pierre-Olivier Zappa. The work done by the researchers on the #oncologie platform will be honored, including interviews with Dr. Bliveau and Paul Levesque.”

 

https://www.linkedin.com/posts/theratechnologies-inc_%C3%A9mission-de-t%C3%A9l%C3%A9-%C3%A0-vos-affaires-activity-6867174824389808128-vSR-





<< Previous
Bullboard Posts
Next >>